Table 2.
The comparison of risk factors between with and without SBR in SMV thrombosis (n=41)
| Characteristic | With SBR (n=4) | Without SBR (n=37) | P-value |
|---|---|---|---|
| Male | 4 (100.0) | 27 (73.0) | 0.564 |
| Age (y) | 70.00±2.82 | 58.94±12.15 | 0.235 |
| Symptom duration (d) | 1.70±0.74 | 12.98±13.27 | 0.010 |
| Decreased bowel enhance | 2 (50.0) | 4 (10.8) | 0.039 |
| Bowel swelling | 2 (50.0) | 19 (51.4) | 0.843 |
| Portal vein extension | 2 (50.0) | 14 (37.8) | 0.853 |
| Splenic vein extension | 2 (50.0) | 8 (21.6) | 0.532 |
| IMV thrombosis | 0 (0.0) | 2 (5.4) | 0.673 |
| White blood cell (×103/μL) | 13.57±0.98 | 9.13±3.15 | 0.093 |
| C-reactive protein (mg/dL) | 6.54±0.85 | 9.01±7.45 | 0.478 |
| Positive blood culture | 4 (100.0) | 12 (32.4) | 0.028 |
Values are presented as number (%) or mean±standard deviation.
SBR, small bowel resection; SMV, superior mesenteric vein.